Melvyn T. Chow

Melvyn T. Chow, Ph.D. is an accomplished immunologist currently serving as Associate Director at Larkspur Biosciences since April 2022. Prior to this role, Melvyn held the position of Associate Director of Immunology at Inzen Therapeutics and served as both Senior Scientist and Junior Faculty/Instructor at Harvard Medical School - Massachusetts General Hospital, where significant contributions to tumor immunology research were made, particularly in relation to chemokines and PD-1 immune checkpoint blockade therapy. Melvyn also completed a research fellowship at QIMR Berghofer Medical Research Institute following the attainment of a Ph.D. in Tumor Immunology from the University of Melbourne, where foundational studies were conducted. Additional academic qualifications include Honours in Science from the University of Melbourne and a Bachelor's degree in Biomedical Science from The University of Western Australia.